COMMUNIQUÉS West-GlobeNewswire

Korro to Participate in Upcoming Investor Conferences
21/11/2024
CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both [...]
Inventiva reports 2024 Third Quarter Financial Information¹
21/11/2024
Cash and cash equivalents at €13.9 million, as of September 30, 2024. Revenues of €1.3 million for the first nine months of 2024. On July 18, 2024, Inventiva issued royalty certificates for an amount of €20.1 million. [...]
Inventiva publie ses informations financières du 3ème trimestre 2024¹
21/11/2024
Trésorerie et équivalents de trésorerie à 13,9 millions d’euros au 30 septembre 2023. Chiffre d’affaires de 1,3 millions d’euros sur les neuf premiers mois de 2024. Emission de certificats de redevance le 18 juillet [...]
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
21/11/2024
WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
21/11/2024
Company Announcement COPENHAGEN, Denmark; November 21, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 10,273 restricted stock units and 10,853 warrants to employees of the Company and [...]
Light-it Launches CompliantChatGPT v2: Advanced AI Solutions to Reduce Medical Burden and Streamline Healthcare Workflows
21/11/2024
AVENTURA, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Light-it, a leading digital product agency specializing in healthtech, announces the release of v2 of CompliantChatGPT. Launched in 2023, this groundbreaking product has [...]
Bio Usawa and Rwandan Government Sign a Memorandum of Understanding to Manufacture Affordable Biologics in Africa
21/11/2024
Company Announces Partnership with Rwanda Development Board to Make Affordable Treatments for Patients in Africa SAN FRANCISCO and KIGALI, Rwanda, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bio Usawa and the Rwanda Development [...]
Delaware North forms robust partnership with Birches Health to power new responsible gaming initiatives
21/11/2024
BUFFALO, N.Y., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Delaware North, a global hospitality and entertainment company with a portfolio of regional casinos and an interactive gaming division, today announced the formation of a [...]
AscellaHealth Ranked Number 154 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
21/11/2024
Attributes 753% Revenue Growth to Advancing Innovative Solutions for Life Sciences, Healthcare Organizations, Payers and Patients BERWYN, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner [...]
Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates
21/11/2024
“Channel Therapeutics” reflects the Company’s focus on developing therapeutics to treat pain utilizing sodium channel blockade and modulation New name is in advance of multiple near-term data readouts FREEHOLD, N.J., [...]
Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings
21/11/2024
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Aeroflow Health Celebrates Nevada’s Elimination of the Diaper Tax
21/11/2024
Through its ongoing advocacy efforts, Aeroflow supported the passing of SB 428 to alleviate the financial burden a diaper tax can impose on families in the state of Nevada ASHEVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE [...]
Gaurav Agarwal Joins Capsa Healthcare as Chief Executive Officer to Lead Next Innovative Growth Phase
21/11/2024
Healthcare Solutions Leader Welcomes Experienced Executive To Drive Key Strategic Initiatives COLUMBUS, Ohio, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare , a leader in advanced healthcare workflow and pharmacy [...]
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
21/11/2024
Funding supports the technology’s transition from academic to clinical use BOSTON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- DANNCE.AI raised $2.6 million in pre-seed funding led by LDV Capital, following initial investment [...]
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
21/11/2024
- Poster presentations on BMB-101 will focus on 5-HT 2C functional selectivity and Phase 1 clinical data - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company [...]
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action
21/11/2024
AUSTIN, Texas, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that new analyses of data from its Phase [...]
Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides
21/11/2024
– License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique design of potent and selective macrocycles for therapeutic [...]
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
21/11/2024
SAN MATEO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral hepatitis and other serious liver diseases, [...]
NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024
21/11/2024
LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]

Pages